Heart Test Laboratories Inc. Common Stock (HSCS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Heart Test Laboratories Inc. Common Stock

NASDAQ | HSCS

3.30

USD

+0.24 (+7.84%)

AT CLOSE (AS OF Apr 17, 2025)

$3.6M

MARKET CAP

P/E Ratio

-7.61

EPS

$14

52 Week High

$2.4

52 Week Low

LIFE SCIENCES

Sector

HSCS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

HSCS Technicals

Tags:

HSCS Earnings

Yearly Income Statement (As of Apr 30, 2024)

Field	Value (USD)
Gross Profit	$13K
Total Revenue	$19K
Cost Of Revenue	$6.1K
Costof Goods And Services Sold	$6.1K
Operating Income	-$6.3M
Selling General And Administrative	$3.4M
Research And Development	$2.9M
Operating Expenses	$6.3M
Investment Income Net	-
Net Interest Income	-$354K
Interest Income	-
Interest Expense	$354K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$95K
Income Before Tax	-$6.6M
Income Tax Expense	-$95K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.6M
Comprehensive Income Net Of Tax	-
Ebit	-$6.3M
Ebitda	-$6.2M
Net Income	-$6.6M

Revenue & Profitability

Earnings Performance

HSCS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Apr 30, 2024)

Field	Value (USD)
Total Assets	$9.5M
Total Current Assets	$7.4M
Cash And Cash Equivalents At Carrying Value	$5.8M
Cash And Short Term Investments	$5.8M
Inventory	$629K
Current Net Receivables	-
Total Non Current Assets	$2.1M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$1.6M
Intangible Assets Excluding Goodwill	$1.6M
Goodwill	-$1.6B
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$917K
Other Non Current Assets	-
Total Liabilities	$2.2M
Total Current Liabilities	$1.8M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$602K
Total Non Current Liabilities	$434K
Capital Lease Obligations	$536K
Long Term Debt	-
Current Long Term Debt	$500K
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$1M
Other Current Liabilities	$701K
Other Non Current Liabilities	-
Total Shareholder Equity	$7.3M
Treasury Stock	-
Retained Earnings	-$67M
Common Stock	$677
Common Stock Shares Outstanding	$353K

yearly Cash Flow (As of Apr 30, 2024)

Field	Value (USD)
Operating Cashflow	-$6.1M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$95K
Capital Expenditures	$125K
Change In Receivables	-
Change In Inventory	$47K
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$10M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$6.6M

yearly Income Statement (As of Apr 30, 2024)

Field	Value (USD)
Gross Profit	$13K
Total Revenue	$19K
Cost Of Revenue	$6.1K
Costof Goods And Services Sold	$6.1K
Operating Income	-$6.3M
Selling General And Administrative	$3.4M
Research And Development	$2.9M
Operating Expenses	$6.3M
Investment Income Net	-
Net Interest Income	-$354K
Interest Income	-
Interest Expense	$354K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$95K
Income Before Tax	-$6.6M
Income Tax Expense	-$95K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.6M
Comprehensive Income Net Of Tax	-
Ebit	-$6.3M
Ebitda	-$6.2M
Net Income	-$6.6M

HSCS News

HSCS Profile

Heart Test Laboratories Inc. Common Stock Profile

Sector: LIFE SCIENCES

Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.00	9.68%	-	409,386,220
STSS	$0.03	20.75%	$522.68K	391,799,240
NVDA	$101.49	-2.87%	$2.48T	292,517,465
HTZ	$8.24	44.31%	$2.54B	266,908,117
FMTO	$0.02	-35.81%	$2.41M	198,396,141

Symbol	Price	Change %	Market Cap	Volume
LLY	$839.96	14.30%	$754.27B	10,853,385
PG	$170.63	2.55%	$400.10B	7,227,061
JNJ	$157.47	2.31%	$379.48B	10,981,067
ABBV	$172.99	0.76%	$306.02B	8,998,056
NVO	$58.08	-7.63%	$282.79B	32,220,629

Symbol	Price	Change %	Market Cap	Volume
MSGM	$2.75	145.54%	$8.75M	36,058,545
SXTC	$2.16	118.42%	$29.73M	51,508,885
ADGM	$1.78	92.81%	$54.65M	114,733,769
PNBK	$3.28	73.55%	$13.04M	1,511,087
RTC	$0.37	72.09%	$10.86M	187,018,434

Symbol	Price	Change %	Market Cap	Volume
JEWL	$0.00	-90.83%	$2.78M	470,134
LXEH	$6.84	-70.25%	$26.82M	1,373,607
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644

Quick Links

HSCS $3.30 (+7.84%) Quote details